Ingevity Corporation (NYSE:NGVT) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Analysts maintain a “Hold” consensus on Ingevity, with three hold ratings and two buys. The average 12-month price target is $80, compared with the stock’s reported price of $69.64.
• Ingevity exceeded quarterly expectations, reporting $1.74 in earnings per share versus the $1.33 consensus estimate and revenue of $314.1 million. Management provided fiscal 2026 EPS guidance of $5.00–$5.45.
• Institutional investors own 91.59% of the company, while insiders sold $1.35 million of stock over the past 90 days. California State Teachers’ Retirement System substantially increased its position during the second quarter.

Ingevity Corporation (NYSE:NGVT - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $80.00.

NGVT has been the topic of a number of recent analyst reports. Wall Street Zen lowered Ingevity from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Ingevity from a "sell (d-)" rating to a "hold (c-)" rating in a report on Friday, July 31st.

Insiders Place Their Bets

In other news, CEO David Li sold 5,000 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the transaction, the chief executive officer owned 120,636 shares of the company's stock, valued at approximately $9,147,827.88. This trade represents a 3.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan Fisher sold 2,709 shares of the firm's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the transaction, the senior vice president owned 15,722 shares of the company's stock, valued at $1,159,025.84. The trade was a 14.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 17,801 shares of company stock valued at $1,347,481 in the last 90 days. Corporate insiders own 0.88% of the company's stock.

Hedge Funds Weigh In On Ingevity

Hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC increased its position in Ingevity by 60.4% during the 2nd quarter. Squarepoint Ops LLC now owns 14,776 shares of the company's stock valued at $1,103,000 after purchasing an additional 5,562 shares during the period. Nykredit A S bought a new stake in shares of Ingevity in the 2nd quarter valued at $158,000. Corient Private Wealth LP acquired a new stake in shares of Ingevity during the second quarter worth $438,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Ingevity during the second quarter worth $254,000. Finally, California State Teachers Retirement System grew its holdings in Ingevity by 7,309.2% during the 2nd quarter. California State Teachers Retirement System now owns 3,003,451 shares of the company's stock worth $224,268,000 after acquiring an additional 2,962,914 shares during the period. 91.59% of the stock is currently owned by institutional investors.

Ingevity Trading Up 0.3%

NYSE:NGVT opened at $69.64 on Monday. The firm has a market capitalization of $2.39 billion, a P/E ratio of 47.38 and a beta of 1.17. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. Ingevity has a one year low of $45.85 and a one year high of $79.29. The company's 50-day simple moving average is $72.63 and its 200 day simple moving average is $71.44.

Ingevity (NYSE:NGVT - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts forecast that Ingevity will post 5.4 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation NYSE: NGVT is a specialty chemicals and materials company that develops products designed to improve performance, sustainability and resource efficiency across a range of industrial and consumer applications. Its businesses serve automotive, infrastructure, industrial, agricultural and other end markets.

The company's portfolio includes activated carbon products used in vehicle evaporative-emissions control systems, industrial air and water purification, and other filtration applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.